Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ito, Hideki
NCT05911841: A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis	Active, not recruiting	2	236	Europe, Canada, Japan, US, RoW	LY3454738, Placebo	Eli Lilly and Company	Atopic Dermatitis	06/25	03/26
NCT06602219: A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis	Recruiting	2	220	Canada, Japan, US	LY4100511, Placebo	DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company	Plaque Psoriasis	07/25	08/25
Kovago, Levente P
NCT05911841: A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis	Active, not recruiting	2	236	Europe, Canada, Japan, US, RoW	LY3454738, Placebo	Eli Lilly and Company	Atopic Dermatitis	06/25	03/26